| 國立臺灣大學 |
2009-01 |
SAFETY OF FLUOROQUINOLONE USE IN PATIENTS WITH HEPATOTOXICITY INDUCED BY ANTI-TUBERCULOSIS REGIMENS
|
何肇基; 陳宜君; 胡賦強; 余忠仁; 楊泮池; 陸坤泰; HO, CHAO-CHI; CHEN, YEE-CHUN; HU, FU-CHANG; YU, CHONG-JEN; YANG, PAN-CHYR; LUH, KWEN-TAY |
| 臺大學術典藏 |
2018-09-10T07:19:40Z |
Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens
|
Ho, C.-C. and Chen, Y.-C. and Hu, F.-C. and Yu, C.-J. and Yang, P.-C. and Luh, K.-T.; Chong-Jen Yu; CHAO-CHI HO; YEE-CHUN CHEN |
| 臺大學術典藏 |
2020-07-21T06:46:33Z |
Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens
|
Chen Y.-C.; Hu F.-C.; Yu C.-J.; Yang P.-C.; Luh K.-T.; CHAO-CHI HO |
| 臺大學術典藏 |
2009 |
Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens
|
Ho C.-C.; YEE-CHUN CHEN; Hu F.-C.; Yu C.-J.; Yang P.-C.; Luh K.-T. |
| 臺大學術典藏 |
2020-12-02T02:34:25Z |
Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens
|
Ho C.-C.; Chen Y.-C.; Hu F.-C.; Yu C.-J.; Pan-Chyr Yang; Luh K.-T.; Ho C.-C.; Chen Y.-C.; Hu F.-C.; Yu C.-J.; PAN-CHYR YANG; Luh K.-T. |
| 臺大學術典藏 |
2021-05-06T01:52:34Z |
Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens
|
Ho C.-C.; YEE-CHUN CHEN; Hu F.-C.; Yu C.-J.; Yang P.-C.; Luh K.-T. |
| 臺大學術典藏 |
2021-05-26T03:34:50Z |
Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens
|
Ho C.-C.; Chen Y.-C.; Hu F.-C.; Yu C.-J.; Yang P.-C.; KWEN-TAY LUH |
| 臺大學術典藏 |
2022-06-27T07:07:50Z |
Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens
|
Ho C.-C.; Chen Y.-C.; Hu F.-C.; CHONG-JEN YU; Yang P.-C.; Luh K.-T. |
| 臺大學術典藏 |
2018-09-10T15:34:00Z |
Safety of gadobutrol in over 23,000 patients: the GARDIAN study, a global multicentre, prospective, non-interventional study
|
Prince, M.R. and Lee, H.G. and Lee, C.-H. and Youn, S.W. and Lee, I.H. and Yoon, W. and Yang, B. and Wang, H. and Wang, J. and Shih, T.T.-F. and Huang, G.-S. and Lirng, J.-F. and Palkowitsch, P. and On Behalf Of The Gardian Study Group; TIFFANY TING-FANG SHIH |
| 臺大學術典藏 |
2020-08-06T07:51:45Z |
Safety of gadobutrol in over 23,000 patients: the GARDIAN study, a global multicentre, prospective, non-interventional study
|
Prince M.R.;Lee H.G.;Lee C.-H.;Youn S.W.;Lee I.H.;Yoon W.;Yang B.;Wang H.;Wang J.;Tiffany Ting-Fang Shih;Huang G.-S.;Lirng J.-F.;Palkowitsch P.;On Behalf Of The Gardian Study Group; Prince M.R.; Lee H.G.; Lee C.-H.; Youn S.W.; Lee I.H.; Yoon W.; Yang B.; Wang H.; Wang J.; TIFFANY TING-FANG SHIH; Huang G.-S.; Lirng J.-F.; Palkowitsch P.; on behalf of the GARDIAN study group |
